Παρασκευή 24 Φεβρουαρίου 2017

Daratumumab receives positive CHMP opinion for rrMM

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended broadening the existing marketing authorisation for daratumumab, marketed by Janssen as Darzalex. If approved by the European Commission,...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2ml9pT1
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις